Q9BYF1 (ACE2_HUMAN) Homo sapiens (Human)

Angiotensin-converting enzyme 2 UniProtKBInterProSTRINGInteractive Modelling

805 aa; Sequence (Fasta) ; (Isoform 3)

Available Structures

116 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
ACE2-B0AT1 complex Heteromer
Q695T7;
14×NAG; 10×NAG;3PH;ZN;20-768
Assess
ACE2-B0AT1 complex, open conformation Heteromer
Q695T7;
21-768
Assess
The 2019-nCoV RBD/ACE2-B0AT1 complex Heteromer
P0DTC2; Q695T7;
14×NAG;NAG; 10×NAG;LEU;ZN;21-768
Assess
Conformation 1 of S-ACE2-B0AT1 ternary complex Heteromer
P0DTC2; Q695T7;
58×NAG; 64×NAG;LEU;ZN;21-768
Assess
Cryo-EM structure of human ACE2 receptor bound to protein encoded by vaccine candidate BNT162b1 Heteromer
P0DTC2;
21-731
Assess
Native Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) Heteromer
NAG;CL;ZN;19-615
Assess
Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 Heteromer
P0DTC2;
ZN;CL;NAG;19-615
Assess
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus huma… Heteromer
P59594; Q56NL1;
NDG;ZN;CL;NAG;19-615
Assess
Crystal structure of spike protein receptor-binding domain from the 2005-2006 SARS coronavirus cive… Heteromer
P59594; Q56NL1;
NDG;ZN;CL;NAG;19-615
Assess
Structure of SARS coronavirus spike receptor-binding domain complexed with its receptor Heteromer
P59594;
NAG;NAG;ZN;CL;19-615
Assess
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus human … Heteromer
P59594;
ZN;CL;19-615
Assess
Inhibitor Bound Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) Heteromer
NAG;CL;ZN;XX5;19-615
Assess
Crystal structure of spike protein receptor-binding domain from SARS coronavirus epidemic strain co… Heteromer
P59594; Q56NL1;
ZN;CL;19-615
Assess
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet … Heteromer
P59594;
ZN;CL;19-615
Assess
Crystal structure of spike protein receptor-binding domain from a predicted SARS coronavirus civet … Heteromer
P59594; Q56NL1;
ZN;CL;19-615
Assess
Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunoc… Heteromer
A0A7U0MIF7;
NAG;NAG;NAG;NAG;NAG;ZN;CL;NAG;19-615
Assess
Crystal structure of spike protein receptor-binding domain from the 2002-2003 SARS coronavirus cive… Heteromer
P59594; Q56NL1;
NDG;ZN;CL;NAG;19-615
Assess
Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39 Heteromer
P0DTC2;
NAG;NAG;NAG;NAG;ZN;SO4;19-615
Assess
Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 … Heteromer
P0DTC2;
NAG;ZN;19-615
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… Heteromer
P59594;
19-615
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… Heteromer
P59594;
19-615
Assess
Trypsin-cleaved and low pH-treated SARS-CoV spike glycoprotein and ACE2 complex, ACE2-bound conform… Heteromer
P59594;
19-615
Assess
SARS-CoV-2 S-ACE2 complex Heteromer
P0DTC2;
18×NAG; 36×NAG;19-615
Assess
The structure of FC08 Fab-hA.CE2-RBD complex Heteromer
P0DTC2;
NAG;19-615
Assess
SARS-COV-2 Spike RBDMACSp25 binding to hACE2 Heteromer
P0DTC2;
NAG;19-615
Assess
SARS-COV-2 Spike RBDMACSp6 binding to hACE2 Heteromer
P0DTC2;
NAG;19-615
Assess
Cryo-EM structure of human ACE2 and GX/P2V/2017 RBD Heteromer
A0A6G6A2Q2;
ZN;NAG;19-615
Assess
Cryo-EM structure of human ACE2 and GD/1/2019 RBD Heteromer
A0A7D6PMV8;
ZN;NAG;19-615
Assess
SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a Heteromer
P0DTC2;
19-615
Assess
SARS-CoV-2 Kappa variant spike protein in complex wth ACE2, state C1 Heteromer
P0DTC2;
19-615
Assess
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2B state Heteromer
P0DTC2;
19-615
Assess
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state Heteromer
P0DTC2;
19-615
Assess
ACE2-RBD in SARS-CoV-2 Kappa variant S-ACE2 complex Heteromer
P0DTC2;
ZN;NAG;19-615
Assess
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state Heteromer
P0DTC2;
19-615
Assess
Cryo-EM structure of SARS-CoV2 RBD-ACE2 complex Heteromer
P0DTC2;
ZN;CL;NAG;19-615
Assess
SARS-CoV-2 Delta S-ACE2-C2a Heteromer
P0DTC2;
19-615
Assess
SARS-CoV-2 Delta S-ACE2-C1 Heteromer
P0DTC2;
19-615
Assess
SARS-CoV-2 Delta S-ACE2-C2b Heteromer
P0DTC2;
19-615
Assess
SARS-CoV-2 Delta S-ACE2-C3 Heteromer
P0DTC2;
19-615
Assess
SARS-CoV-2 Delta S-RBD-ACE2 Heteromer
P0DTC2;
19-615
Assess
SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state Heteromer
P0DTC2;
19-615
Assess
ACE2-RBD in SARS-CoV-2 Beta variant S-ACE2 complex Heteromer
P0DTC2;
ZN;NAG;19-615
Assess
SARS-CoV-2 Kappa variant spike protein in C3 state Heteromer
P0DTC2;
19-615
Assess
SARS-CoV-2 Kappa variant spike protein in C2b state Heteromer
P0DTC2;
19-615
Assess
Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with human ACE2 Heteromer
P0DTC2;
NAG;ZN;19-614
Assess
SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2 Heteromer
P0DTC2;
NAG;NAG;EDO;ZN;19-614
Assess
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (T2… Heteromer
P0DTC2;
NAG;19-614
Assess
Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2 Heteromer
P0DTC2;
NAG;ZN;19-614
Assess
Structure of SARS-CoV-2 Beta variant spike receptor-binding domain complexed with human ACE2 Heteromer
P0DTC2;
NAG;NAG;ZN;19-614
Assess
Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2 Heteromer
P0DTC2; P59594;
NAG;NAG;ZN;CL;EDO;NAG;19-614
Assess
Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (S1… Heteromer
P0DTC2;
NAG;19-614
Assess
Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with human ACE2 Heteromer
P0DTC2;
NAG;ZN;19-614
Assess
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immuni… Heteromer
P0DTC2;
NAG;CL;SO4;NA;PG5;ZN;NAG;PGE;19-614
Assess
Structure of SARS-CoV-2 Gamma variant spike receptor-binding domain complexed with human ACE2 Heteromer
P0DTC2;
NAG;NAG;ZN;19-614
Assess
Structure of SARS-CoV-2 Alpha variant spike receptor-binding domain complexed with human ACE2 Heteromer
P0DTC2;
NAG;NAG;ZN;19-614
Assess
Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2 Heteromer
A0A6B9WHD3;
NAG;NAG;ZN;19-614
Assess
Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in co… Heteromer
P0DTC2;
NAG;19-614
Assess
Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human … Heteromer
Q6Q1S2;
NAG;19-614
Assess
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 Heteromer
P0DTC2;
NAG; 46×NAG;19-614
Assess
ACE2-RBD Focused Refinement Using Symmetry Expansion of Applied C3 for Triple ACE2-bound SARS-CoV-2… Heteromer
P0DTC2;
NAG;NAG;19-614
Assess
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 Heteromer
P0DTC2;
NAG; 55×NAG;19-614
Assess
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5 Heteromer
P0DTC2;
NAG; 44×NAG;19-614
Assess
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5 Heteromer
P0DTC2;
NAG; 48×NAG;19-614
Assess
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5 Heteromer
P0DTC2;
NAG; 56×NAG;19-614
Assess
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4 Heteromer
P0DTC2;
NAG; 53×NAG;19-614
Assess
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectod… Heteromer
P0DTC2;
NAG;19-614
Assess
Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectod… Heteromer
P0DTC2;
18×NAG; 32×NAG;19-614
Assess
Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 … Heteromer
P0DTC2;
NAG;NAG;NAG;19-614
Assess
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting … Heteromer
P0DTC2;
37×NAG; 13×NAG;19-614
Assess
Local refinement of SARS-CoV-2 S-Beta variant (B.1.351) RBD and Angiotensin-converting enzyme 2 (AC… Heteromer
P0DTC2;
NAG;NAG;19-614
Assess
Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting … Heteromer
P0DTC2;
31×NAG; 13×NAG;19-614
Assess
Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enz… Heteromer
P0DTC2;
31×NAG; 17×NAG;19-614
Assess
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme… Heteromer
P0DTC2;
30×NAG; 29×NAG;19-614
Assess
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting … Heteromer
P0DTC2;
43×NAG; 14×NAG;19-614
Assess
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting … Heteromer
P0DTC2;
38×NAG; 16×NAG;19-614
Assess
Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2)… Heteromer
P0DTC2;
NAG;NAG;19-614
Assess
Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 … Heteromer
P0DTC2;
NAG;NAG;NAG;19-614
Assess
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme… Heteromer
P0DTC2;
30×NAG;NAG; 19×NAG;19-614
Assess
Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting … Heteromer
P0DTC2;
37×NAG; 15×NAG;19-614
Assess
Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme… Heteromer
P0DTC2;
29×NAG; 26×NAG;19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectod… Heteromer
P0DTC2;
18×NAG; 26×NAG;19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2… Heteromer
P0DTC2;
NAG;19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound t… Heteromer
P0DTC2;
NAG;19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to huma… Heteromer
P0DTC2;
18×NAG; 26×NAG;19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to huma… Heteromer
P0DTC2;
NAG;19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectod… Heteromer
P0DTC2;
NAG;19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound t… Heteromer
P0DTC2;
18×NAG; 28×NAG;19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2… Heteromer
P0DTC2;
NAG;19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2… Heteromer
P0DTC2;
18×NAG; 28×NAG;19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound t… Heteromer
P0DTC2;
18×NAG; 42×NAG;19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2… Heteromer
P0DTC2;
18×NAG; 28×NAG;19-614
Assess
Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound t… Heteromer
P0DTC2;
NAG;19-614
Assess
SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain Heteromer
P0DTC2;
ZN;NAG;19-613
Assess
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound Heteromer
P0DTC2;
23×NAG;ZN;19-613
Assess
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction Heteromer
P0DTC2;
19-613
Assess
SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound Heteromer
P0DTC2;
19-613
Assess
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction Heteromer
P0DTC2;
19-613
Assess
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound Heteromer
P0DTC2;
19-613
Assess
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) Heteromer
P0DTC2;
NAG;NAG;ZN;19-613
Assess
S protein of SARS-CoV-2 in complex bound with T-ACE2 Heteromer
P0DTC2;
35×NAG; 34×NAG;21-615
Assess
Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement) Heteromer
P0DTC2;
NAG;NAG;ZN;19-613
Assess
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and … Heteromer
P0DTC2;
27×NAG; 28×NAG;21-615
Assess
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound) Heteromer
P0DTC2;
26×NAG; 30×NAG;21-615
Assess
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (2 up RBD and 1 PD bound) Heteromer
P0DTC2;
27×NAG; 28×NAG;21-615
Assess
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and … Heteromer
P0DTC2;
32×NAG; 29×NAG;21-615
Assess
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and … Heteromer
P0DTC2;
32×NAG; 29×NAG;21-615
Assess
SARS-CoV-2 B.1.1.7 S-ACE2 complex Heteromer
P0DTC2;
16×NAG; 27×NAG;19-613
Assess
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 Heteromer
P0DTC2;
18×NAG; 34×NAG;19-613
Assess
Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 (focused refinemen… Heteromer
P0DTC2;
NAG;19-613
Assess
SARS-COV-2 Spike RBDMACSp36 binding to hACE2 Heteromer
P0DTC2;
NAG;19-612
Assess
SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound Heteromer
P0DTC2;
20×NAG; 40×NAG;21-613
Assess
SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound Heteromer
P0DTC2;
24×NAG; 42×NAG;21-613
Assess
SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound Heteromer
P0DTC2;
17×NAG; 36×NAG;21-613
Assess
The co-crystal structure of ACE2 with Fab Heteromer
ZN;23-613
Assess
SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles Heteromer
P59594;
NAG;NAG; 11×NAG;NAG;19-562
Assess
Importin alpha bound to the C-terminus of ACE2 Heteromer
P52293;
768-774
Assess

3 SWISS-MODEL models

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomerNAG;ZN;0.846m17.1.B21-768
100.00
Assess
Heteromer
Q9BYF1; P0DTC2;
NAG;0.787mjm.119-614
99.45
Assess
Heteromer
P0DTC2;
NAG;NAG;0.737kj2.121-613
99.67
Assess

2 SWISS-MODEL models built on isoform sequence

IsoformOligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
Isoform 3monomerZN;0.786m18.1.B7-422
99.12
Assess
Isoform 3monomer0.573abm.1.B380-402
13.04
Assess